India Glycols Ltd
- Market Cap ₹ 2,583 Cr.
- Current Price ₹ 834
- High / Low ₹ 979 / 512
- Stock P/E 16.8
- Book Value ₹ 530
- Dividend Yield 0.90 %
- ROCE 9.03 %
- ROE 7.20 %
- Face Value ₹ 10.0
Pros
- Company has been maintaining a healthy dividend payout of 17.9%
Cons
- The company has delivered a poor sales growth of -2.63% over past five years.
- Company has a low return on equity of 7.71% over last 3 years.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Sector: Alcoholic Beverages Industry: Breweries & Distilleries
Quarterly Results
Standalone Figures in Rs. Crores / View Consolidated
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | TTM | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2,624 | 3,334 | 2,885 | 2,557 | 2,322 | 2,473 | 3,028 | 3,356 | 2,714 | 2,280 | 2,863 | 2,650 | 2,987 | |
2,285 | 2,965 | 2,674 | 2,420 | 2,140 | 2,237 | 2,703 | 2,936 | 2,436 | 2,022 | 2,611 | 2,353 | 2,597 | |
Operating Profit | 339 | 368 | 211 | 137 | 182 | 237 | 325 | 420 | 278 | 258 | 252 | 298 | 389 |
OPM % | 13% | 11% | 7% | 5% | 8% | 10% | 11% | 13% | 10% | 11% | 9% | 11% | 13% |
9 | 12 | -164 | -15 | -50 | 7 | 10 | 17 | 52 | 34 | 237 | 10 | 25 | |
Interest | 113 | 133 | 134 | 158 | 133 | 122 | 118 | 136 | 90 | 73 | 62 | 95 | 114 |
Depreciation | 78 | 82 | 83 | 81 | 65 | 68 | 69 | 72 | 73 | 76 | 76 | 90 | 103 |
Profit before tax | 157 | 165 | -170 | -117 | -66 | 54 | 149 | 229 | 166 | 143 | 352 | 123 | 197 |
Tax % | 33% | 27% | 30% | 47% | 36% | 17% | 34% | 35% | 23% | 41% | 19% | 20% | |
105 | 121 | -120 | -61 | -42 | 45 | 98 | 148 | 128 | 84 | 285 | 99 | 154 | |
EPS in Rs | 39.06 | -38.61 | -19.81 | -13.67 | 14.38 | 31.68 | 47.87 | 41.43 | 27.23 | 92.18 | 31.89 | 49.77 | |
Dividend Payout % | 8% | 15% | -3% | 0% | 0% | 7% | 13% | 13% | 14% | 22% | 8% | 24% |
Compounded Sales Growth | |
---|---|
10 Years: | -2% |
5 Years: | -3% |
3 Years: | -1% |
TTM: | 12% |
Compounded Profit Growth | |
---|---|
10 Years: | -1% |
5 Years: | 3% |
3 Years: | -5% |
TTM: | 79% |
Stock Price CAGR | |
---|---|
10 Years: | 23% |
5 Years: | 26% |
3 Years: | 24% |
1 Year: | 57% |
Return on Equity | |
---|---|
10 Years: | 8% |
5 Years: | 10% |
3 Years: | 8% |
Last Year: | 7% |
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Sep 2023 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Equity Capital | 28 | 31 | 31 | 31 | 31 | 31 | 31 | 31 | 31 | 31 | 31 | 31 | 31 |
Reserves | 454 | 598 | 475 | 424 | 771 | 815 | 910 | 1,043 | 1,127 | 1,214 | 1,481 | 1,557 | 1,610 |
1,993 | 1,639 | 1,927 | 2,138 | 1,120 | 977 | 766 | 930 | 928 | 1,064 | 969 | 1,112 | 1,108 | |
442 | 696 | 776 | 564 | 1,555 | 1,540 | 1,637 | 1,711 | 1,941 | 1,765 | 1,787 | 1,844 | 2,043 | |
Total Liabilities | 2,916 | 2,964 | 3,209 | 3,158 | 3,478 | 3,363 | 3,345 | 3,715 | 4,027 | 4,074 | 4,267 | 4,543 | 4,792 |
1,062 | 1,092 | 1,188 | 1,032 | 1,917 | 2,003 | 2,053 | 2,074 | 2,134 | 2,102 | 2,232 | 2,717 | 2,814 | |
CWIP | 97 | 194 | 122 | 142 | 167 | 78 | 76 | 124 | 163 | 119 | 237 | 125 | 102 |
Investments | 72 | 229 | 57 | 82 | 29 | 26 | 26 | 26 | 29 | 29 | 29 | 2 | 0 |
1,685 | 1,450 | 1,841 | 1,901 | 1,365 | 1,257 | 1,190 | 1,491 | 1,702 | 1,824 | 1,770 | 1,700 | 1,877 | |
Total Assets | 2,916 | 2,964 | 3,209 | 3,158 | 3,478 | 3,363 | 3,345 | 3,715 | 4,027 | 4,074 | 4,267 | 4,543 | 4,792 |
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
-47 | 769 | -138 | -154 | 1,223 | 302 | 487 | 148 | 344 | 142 | 114 | 326 | |
-222 | -242 | 2 | 155 | -79 | -41 | -145 | -133 | -156 | -157 | 77 | -330 | |
294 | -526 | 106 | -1 | -1,161 | -261 | -342 | 7 | -212 | 16 | -188 | -0 | |
Net Cash Flow | 25 | 1 | -30 | -1 | -17 | 1 | 0 | 22 | -24 | 0 | 4 | -5 |
Ratios
Standalone Figures in Rs. Crores / View Consolidated
Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Debtor Days | 37 | 33 | 56 | 62 | 59 | 59 | 41 | 36 | 77 | 58 | 51 | 60 |
Inventory Days | 151 | 77 | 106 | 107 | 124 | 129 | 87 | 123 | 147 | 168 | 147 | 209 |
Days Payable | 49 | 76 | 91 | 55 | 117 | 145 | 152 | 142 | 156 | 162 | 137 | 209 |
Cash Conversion Cycle | 139 | 33 | 71 | 115 | 66 | 43 | -24 | 18 | 69 | 65 | 61 | 60 |
Working Capital Days | 94 | 59 | 95 | 107 | 70 | 19 | 1 | 10 | 13 | 30 | 41 | 30 |
ROCE % | 12% | 13% | 6% | 4% | 6% | 9% | 15% | 20% | 13% | 9% | 8% | 9% |
Documents
Announcements
- Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A 19 Apr
- Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate 18 Apr
- Compliance Certificate Under Regulation 40(9) Of SEBI (LODR) Regulations, 2015 For The Year Ended 31St March, 2024. 10 Apr
- Disclosure Under Regulation 30 9 Apr
-
Compliance Certificate For The Year Ended 31St March, 2024
8 Apr - Compliance Certificate for the year ended 31st March, 2024 duly signed by Compliance Officer of the Company and M/s. MCS Share Transfer Agent Limited, Registrar …
Annual reports
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from nse
-
Financial Year 2013
from bse
-
Financial Year 2012
from bse
-
Financial Year 2011
from bse
-
Financial Year 2011
from nse
Concalls
-
Feb 2024Transcript PPT
-
Nov 2023Transcript PPT
-
Aug 2023Transcript PPT REC
-
May 2023Transcript PPT
-
Feb 2023Transcript PPT
-
Feb 2023TranscriptNotesPPT
-
Nov 2022Transcript PPT
-
Aug 2022Transcript PPT
-
Jun 2022Transcript PPT
-
Feb 2022Transcript PPT
-
Nov 2021Transcript PPT
-
Aug 2021Transcript PPT
Business Divisions
Chemicals: The Co. is engaged in the manufacturing of chemicals like Ethylene glycols, Ethoxylates, and PEG, Glycol ethers and acetates, and Performance chemicals. [1]
Industrial Gases: The Co. produces cryogenic gases like Liquid Oxygen, Liquid Nitrogen, And Liquid Argon. [2]
Ennature Biopharma: The Co. has a wholly-owned subsidiary engaged in the manufacture of natural active pharmaceutical ingredients (APIs), nutraceuticals, natural food colors, standardized herbal extracts, and spice extracts for the beverage, dietary supplement, functional food, pharmaceutical and cosmeceutical industries. [3]
Natural Gums: Natural Gums Division is engaged in the manufacturing & supply of Guar Gum and other hydrocolloid products. [4]
Spirits: The Co. is also engaged in the manufacturing of spirits and has a total installed capacity of 280,000 KLPA for the production of ethyl alcohol, out of which, 80,000 KLPA is for potable alcohol. [5]